Cartoon cure for transplant jitters: study tests animated education
NCT ID NCT07514442
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a short animated video can lower anxiety in children (ages 4-10) getting a stem cell transplant and their parents. Half the families watch the video, the other half get standard verbal instructions. Researchers measure anxiety and satisfaction before and after the education. The goal is to see if animation makes the process less scary and more satisfying for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 34 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
4 to 10 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Children: Aged 4 to 10 years. Scheduled for hematopoietic stem cell transplantation. No previous history of hematopoietic stem cell transplantation. Ability to communicate verbally in Turkish. No diagnosed cognitive impairment. Provided age-appropriate verbal assent if aged 7 years or older. Written informed consent provided by a legal parent or guardian. Parents: Parent or legal guardian of a child aged 4 to 10 years scheduled for hematopoietic stem cell transplantation. Remaining with the child as the primary caregiver/companion throughout the HSCT hospitalization. Ability to communicate verbally in Turkish. Willingness to participate and provision of written informed consent. Exclusion Criteria: Children: Native language other than Turkish or significant difficulty communicating in Turkish. Previous hematopoietic stem cell transplantation. Development of severe clinical complications before or during transplantation requires modification of the treatment protocol. Transfer to another clinic prior to transplantation. Significant emotional distress during the animation intervention, as assessed by the research team. Parents: Native language other than Turkish or significant difficulty communicating in Turkish. Change in caregiver/companion role during the transplantation process.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hematopoetic stem cell transplantation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
Ankara, Cankaya, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug cocktail aims to stop leukemia return after transplant
- Pedal power: could a bike ride supercharge Cancer-Fighting cells?
- New cell therapy aims to supercharge Kids' immune cells after transplant
- New study aims to ease the burden of stem cell recovery for patients and families
- New drug combo aims to speed blood recovery in cancer transplants
- Massive study to track stem cell patients in ICU